Why is Meghmani Organics Ltd falling/rising?

Jan 10 2026 01:37 AM IST
share
Share Via
As of 09 January, Meghmani Organics Ltd’s stock price has fallen to ₹60.05, reflecting a 2.12% decline on the day and continuing a downward trend that has seen the share price drop by over 7% in the past week, significantly underperforming the broader Sensex index.




Recent Price Movement and Market Context


On 09 January, Meghmani Organics witnessed a notable drop in its share price, falling by ₹1.30 or 2.12% to close at ₹60.05. This decline follows two consecutive days of losses, during which the stock has shed approximately 4.58%. Intraday, the share touched a low of ₹60, reflecting selling pressure near the lower end of its trading range. Despite this, the stock marginally outperformed its sector, Dyes & Pigments, which declined by 2.63% on the same day.


Trading volumes have increased, with delivery volumes rising by 16.66% on 08 January compared to the five-day average, signalling heightened investor participation. However, the weighted average price indicates that most trading occurred near the day’s low, suggesting that sellers dominated the session. Furthermore, Meghmani Organics is trading below all key moving averages—5-day, 20-day, 50-day, 100-day, and 200-day—indicating a bearish technical setup.



Our latest monthly pick, this Large Cap from Aluminium & Aluminium Products, is outperforming the market! See the analysis that helped our Investment Committee select this winner.



  • - Market-beating performance

  • - Committee-backed winner

  • - Aluminium & Aluminium Products standout



Read the Winning Analysis →



Strong Quarterly Performance Contrasted by Long-Term Weakness


Meghmani Organics has reported positive results for five consecutive quarters, with quarterly PAT reaching ₹11.55 crores, representing a remarkable 145.2% growth compared to the previous four-quarter average. Net sales for the latest six months stood at ₹1,190.88 crores, up 24.34%, while the company’s half-yearly return on capital employed (ROCE) peaked at 7.30%. These figures highlight robust recent operational performance and improving profitability metrics.


Additionally, the stock trades at an attractive valuation, with a ROCE of 4.6 and an enterprise value to capital employed ratio of 1, suggesting it is undervalued relative to its peers. Despite a one-year stock return of -26.33%, the company’s profits have surged by 148.2%, resulting in a low PEG ratio of 0.3, which typically signals undervaluation relative to earnings growth.


However, Long-Term Challenges Weigh on Investor Confidence


Despite recent earnings momentum, Meghmani Organics faces significant long-term headwinds. The company’s operating profits have declined at a compound annual growth rate (CAGR) of -18.02% over the past five years, indicating structural challenges in sustaining profitability. Its average return on equity (ROE) is a modest 6.03%, reflecting limited efficiency in generating shareholder returns.


Institutional investor participation has also waned, with a 0.83% reduction in stake over the previous quarter, leaving institutions holding only 1.52% of the company. This decline is notable given that institutional investors typically possess superior analytical resources and often lead market sentiment shifts. The stock’s consistent underperformance against benchmarks such as the Sensex and BSE500 over one, three, and five-year periods further dampens enthusiasm, as it has generated negative returns while the broader market indices have advanced significantly.



Considering Meghmani Organi.? Wait! SwitchER has found potentially better options in Pesticides & Agrochemicals and beyond. Compare this Smallcap with top-rated alternatives now!



  • - Better options discovered

  • - Pesticides & Agrochemicals + beyond scope

  • - Top-rated alternatives ready



Compare & Switch Now →



Investor Takeaway


Meghmani Organics’ share price decline on 09 January reflects a market grappling with the juxtaposition of strong recent earnings growth against a backdrop of weak long-term fundamentals and subdued institutional interest. While the company’s recent quarterly results and sales growth are encouraging, the persistent underperformance relative to benchmarks and declining operating profit trends over five years raise concerns about sustainable value creation.


Technically, the stock’s position below all major moving averages and the increased trading volume near lower price levels suggest continued selling pressure in the near term. Investors should weigh the company’s attractive valuation and profit growth against its historical challenges and cautious institutional stance before making investment decisions.





{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News